Bayer Invests €100m Into Making Consumer Heath Brands Sustainable

Bayer is reinvesting 2% of its Consumer Health division’s sales to drive the sustainable use of the company’s OTC brands and “help create a world where people can live healthier lives.”

NicoElNino/Shutterstock.com
• Source: Shutterstock

Bayer AG is investing €100m ($113m) in its Consumer Health division to “enable sustainable innovation, production and consumption” of major OTC brands like Aspirin, Bepanthen, Claritin and Elevit.

More from International

Stada Expands Oilatum Range To Meet Saudi Arabia’s Skin-Care Needs

 
• By 

Stada launches nine new Oilatum products in Saudi Arabia including “rich moisturising creams for intense hydration, gentle body washes for daily cleansing, and baby-specific products like soothing bath bubbles and head-to-toe wash.”

Bayer And GSCF Paper Outlines ‘Practical Actions’ For Scaling Self-Care Globally

 
• By 

Bayer Consumer Health, the Global Self-Care Federation and the Business Council for International Understanding outline in a paper how industry can work with multilateral organizations, governments, financial institutions, and stakeholders to "recognize and champion self-care as a fundamental driver of global health progress."

UK Honors PAGB’s Riddalls And ISF’s Webber For Self-Care Service

 
• By 

PAGB CEO Michelle Riddalls and ISF president emeritus David Webber have been awarded OBEs for their services to consumer health and self-care.

People On The Move: Appointments At GSCF, MENAP-SCI, Clasado

 
• By 

A round-up of the latest consumer health industry appointments: GSCF names next director general, MENAP-SCI elects chairman; Clasado hires BD director.

More from Geography

Eisai Switches Proton Pump Inhibitor Rabeprazole To OTC In Japan

 
• By 

Eisai aims to support people in Japan with severe heartburn and discomfort caused by gastric acid related conditions by switching from prescription to OTC status its Pariet-branded proton pump inhibitor.

AESGP: ‘No Evidence’ Of Antimicrobial Resistance With OTC Antifungals Or Antivirals

 
• By 

Two AESGP papers reviewing the evidence for AMR risk associated with a range of OTC antifungals and antivirals conclude there is litte to no risk associated with the responsible self-care use of such medicines.

Over The Counter: What To Expect From The 61st AESGP Annual Meeting, With Jurate Švarcaite

 
• By 

HBW Insight speaks to AESGP director general Jurate Švarcaite about what's on the agenda for the upcoming 61st AESGP Annual Meeting, which will take place in Warsaw, Poland, between 2-4 June. Highlights include the role of prevention in self-care, discussions about how regulators will ensure the competitiveness of European industry on the world stage and incoming changes to sustainability legislation.